BioAtla's Unattributed VC Round

BioAtla raised a round of funding on June 11, 2015. Investors include Pfizer Venture Investments.

BioAtla is a global biotechnology company developing novel monoclonal antibody and other protein therapeutic products utilizing our proprietary technologies for product design and development. The com…

Articles about BioAtla's Unattributed VC Round: